During the go-shop period, HCG contacted 38 potential buyers, three of which entered into confidentiality agreements with the Group for access to nonpublic information. HCG did not receive any other acquisition offers during the go-shop period.
Completion of the arrangement is subject to obtaining the required approval of HCG's shareholders, court, and regulatory approvals. DBRS Morningstar will review its ratings for HCG once the approvals are in place and there is more clarity on the transaction.
Notes:
For more information on this credit or on this industry, visit www.dbrsmorningstar.com or contact us at info@dbrsmorningstar.com' >info@dbrsmorningstar.com.
Tel. +1 416 593-5577
(C) 2023 Electronic News Publishing, source